CAS: 881995-69-3; Benzenebutanoic Acid, β-Amino-2,4,5-Trifluoro-, Methyl Ester, (βr)

该化合物是化学化合物,其独特结构包括苯丁酸和甲基酯功能组,其特点是:一种生物活动潜力的丁基氨基化合物,以及三种三氟甲基混合物,这些混合物增强了其亲脂性,并可能影响其活性和与生物目标的相互作用;氟基原子的存在通常比非氟类比具有更大的稳定性和改变的药用动力特性;作为甲基酯,该化合物与酸形式相比,可能表现出不同的溶性和再活性特征;该化合物可能因其在药物中的潜在用途,特别是用于特定生物活动的化合物设计,因而对医药化学和药物开发感兴趣;其立体化学学,如(bR)-指认所示,表明它可能表现出气质特性,从而对其生物互动和功效产生重大影响.

结构式图片

上下游产品

CAS号486460-00-8 (3R)-N-叔丁氧羰基-3-... | CAS号486460-32-6 西他列汀

合成工艺路线路线简述

  • 合成目标产物 Benzenebutanoicacid,B-Amino-2,4,5-Trifluoro-,Methylester,(Br)- 主要起始原料 (R)-Methyl 3-Amino-4-(2,4,5-Trifluorophenyl) Butanoate .(R)-2-Hydroxy-2-Phenylacetate
  • 881995-70-6 = 881995-69-3
    反应条件:1.1 Reagents: Water,Trichlorosilane Catalysts: 2-Piperidinecarboxamide,N-[(1S,2R)-2-[(Ethenyldimethylsilyl)Oxy]-1,2-Diphenylet... Solvents: Dichloromethane; -30 °C; 36 H,-30 °C1.2 Reagents: Sodium Bicarbonate Solvents: Water
    标题:Organocatalytic Asymmetric Reduction Of N-Unsubstituted β-Enamino Ester With Hsicl3
    作者:Liang,Yushi; Et Al
    参考文献:Tetrahedron Letters 日期:2023 卷标:122]

    1314734-71-8 = 881995-69-3
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol; 48 H,Rt
    标题:Synthesis Of The Key Intermediate Of Type 2 Diabetes Drug Sitagliptin
    作者:Liu,Ying-Shuai; Et Al
    参考文献:Zhongguo Yaowu Huaxue Zazhi 日期:2012 卷标:22(5) 页码:360-363]

    = 881995-69-3
    反应条件:1.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Di-Tert-Butyl Dicarbonate; 48 H,500 Kpa
    标题:Synthesis Of Type 2 Anti-Diabetic Drug Sitagliptin Phosphate
    作者:Lu,Cheng-Lin; Et Al
    参考文献:Zhongguo Xinyao Zazhi 日期:2014 卷标:23(13) 页码:1574-1578
Boc-(R)-3-氨基-4-(2,4,5-三氟苯基)丁酸置于盐酸,1-羟基苯并三唑,盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺,N,N-二异丙基乙胺体系中,用 二氯甲烷,水 作为反应溶剂,化学反应生成 西他列汀-Int A8
参考文献:西他列汀游离碱及西他列汀磷酸盐一水合物的合成方法
标题:西他列汀游离碱及西他列汀磷酸盐一水合物的合成方法
摘要:本发明涉及一种西他列汀游离碱及西他列汀磷酸盐一水合物的合成方法,本发明通过除去干燥的hobt或改为hobt水合物,在工艺中除去溶剂dmf以及在生产过程中使用易于回收的简单溶剂,降低了生产成本,提高了反应安全性;本发明从式2化合物到式6化合物的原位法工艺可以提高产量并减少操作步骤,用用其他溶剂代替甲醇或异丙醇ipa,从而避免了产生式7,式8和式9所示的杂质,从而大大提高了产物纯度及收率,西格列汀游离碱的HPLC纯度在99%以上.

海关参考信息

专利信息


专利号:WO-2023021529-A1
优先权日:2021-08-17
标题:Improved enzymatic synthesis of sitagliptin or its salts thereof
发明人:DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; WADHAVANE SACHIN; MURALIDHARAN KRISHNA; TRIVIKRAM SREENATH
权利人:FERMENTA BIOTECH LTD
摘要:The present invention discloses an improved enzymatic synthesis of Sitalgiptin or its pharmaceutically acceptable salts in good yield and purity. The present invention provides novel intermediate (R)- 3-Acetamido-4-(2,4,5-Trifluorophenyl) butanoic acid (5).

专利号:US-8846916-B2
优先权日:2009-05-11
标题:Sitagliptin synthesis
发明人:GORE VINAYAK GOVIND; GADAKAR MAHESHKUMAR; BHOSLE PRIYANKA; SHINDE SURESH
权利人:GORE VINAYAK GOVIND; GADAKAR MAHESHKUMAR; BHOSLE PRIYANKA; SHINDE SURESH; GENERICS UK LTD
摘要:The present invention relates to novel processes for the preparation of enantiomerically enriched β-amino acid derivatives such as β-amino esters useful for the synthesis of enantiomerically enriched biologically active molecules such as sitagliptin. The key step involves the resolution of the racemate with mandelic acid.

专利号:WO-2013114173-A1
优先权日:2012-01-30
标题:A novel process for the preparation of sitagliptin
发明人:MALLELA SAMBHU PRASAD SARMA; HAVALE SHRIKANT HANUMANTAPPA; BODDEPALLI NAGABHUSHANA RAO; GUNJI NAGARJUNA; MOKKAPATI BHAVANI SANKAR
权利人:SMILAX LAB LTD; MALLELA SAMBHU PRASAD SARMA; HAVALE SHRIKANT HANUMANTAPPA; BODDEPALLI NAGABHUSHANA RAO; GUNJI NAGARJUNA; MOKKAPATI BHAVANI SANKAR
摘要:The present invention is directed to a process for the preparation of enantiomerically enriched β-amino acid derivatives which are important chiral building blocks and intermediates in pharmaceuticals. More specifically, the invention pertains to a novel process for practically convenient and economically producing enantiomerically enriched β-amino acid derivatives which are useful for the synthesis of amide inhibitors of dipeptidyl peptidase IV like Sitagliptin, which have been used to treat type 2 diabetes.

专利号:WO-2023012819-A1
优先权日:2021-07-31
标 题 :Recombinant transaminase polypeptides
发明人:VENKATESAN SURYANARAYANAN; SINGH ANKITA; PANDE KAJAL; PRAHLAD DWARAKANATH; KULKARNI NAVEEN; SOKKAR PANDIAN; ASHOKAN ANISHA; SRINIVASAN MUDAMBI ROHIT
权利人:QUANTUMZYME LLP
摘要:The present invention provides recombinant transaminase polypeptides, fusion protein comprising the same and process of designing the same. Further, the present invention provides a process of preparing chiral amines catalyzed by the recombinant transaminase polypeptides. Also, the present invention provides uses of the recombinant transaminase polypeptides. The recombinant transaminases of the invention lead to reduced cost of synthesis of enantiopure chiral amines along with high yield and purity.

专利号:US-8524936-B2
优先权日:2011-05-18
标 题:Manufacturing process for sitagliptin from L-aspartic acid
发明人:SOUKUP MILAN
权利人:SOUKUP MILAN
摘要:The present invention relates to a novel manufacturing process of pharmaceutically active compound of formula I used as oral anti-diabetic drug. Starting from L-aspartic acid derivate of formula IV the invention describes preparation of the chiral (R)-β-amino acid of formula II known as a precursor in the synthesis of Sitagliptin (formula I).

专利号:CN-104805069-A
优先权日:2015-02-06
标 题:A kind of immobilized transaminase and its application in the synthesis of sitagliptin intermediate
杭州国瑞生物科技有限公司
⚠️ 未注册 · 未认证企业
⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
数据来源于公开网络搜索,平台未作核实,请自行辨别。
🏢敬请 企业认领
🏬开设公司展台
📢获取免费会员权益
🎖️点亮专属注册企业标签
📇展现公司完整信息 样本查看立即注册认领 →
网址: http://www.guoruibio.com
企业联系👤
📞杭州国瑞生物科技有限公司 ⚠️参考联系方式
联系人:刘先生

手机:13761625031
传真:0571-85186835
邮箱:sales@guoruibio.com
通信地址: 浙江杭州市滨江区江二路400号和瑞科技园S-1幢1502室
邮编: 310052
🆔 联系时候可告知是从"百琢研"平台获取的信息.
⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

地址:浙江杭州市滨江区江二路400号和瑞科技园S-1幢1502室
⚠️ 未注册 · 未认证企业
注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
第 1 / 1 页
现货

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知